Medicine
Andembry 200 mg/1.2 mL injection
Andembry 200 mg/1.2 mL injection is a prescription medicine containing Garadacimab for subcutaneous use, marketed by Csl, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store the prefilled autoinjector and prefilled syringe with needle safety…
Key facts
- Active ingredient (INN)
- Garadacimab
- Brand
- Andembry
- Strength
- 200 mg/1.2 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 1 syringe of 1.2 mL
- Marketing authorisation holder
- Csl
- Manufacturer
- Csl
- Origin register
- US FDA, United States
- Storage
- Store the prefilled autoinjector and prefilled syringe with needle safety device refrigerated at 36°F to 46°F (2°C - 8°C).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B06AC07 Garadacimab
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 16 June 2025
- Identifiers
- RxCUI 2717175, 2717182DailyMed set ID 07b0b671-db81-49f0-a402-0c0219db7fa2NDC 63833-925Application BLA761367
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 syringe, glass in 1 carton / 1.2 mL in 1 syringe, glass | 63833-925-01 | Csl | 16 June 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Garadacimab is a prescription medicine indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older. It is available as injection for subcutaneous use. MedsAcross supplies Garadacimab for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about GaradacimabFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ANDEMBRY prescribing information (CSL) · U.S. National Library of Medicine, DailyMed
- Andembry: European public assessment report (EPAR) · European Medicines Agency
Need Andembry 200 mg/1.2 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.